Having been in this thing for 12+ years (3-4 rounds of funding, 2-3 reverse splits), I would take the 20$ buyout within the next 12-18 months. After that, depending on CYRX execution, it would need to be more...
hyperopia - For surprises I just mean any news on more Trials or FDA approvals this year. Also any nice bump in 4Q earnings which we all expect a small increase this year to get us started for what I think is going to be an awesome 2018.
Assuming no further dilution and adding in all warrants a $1B market cap would mean approx a $40 share price. Well over $1B would mean $45? $50??
Just typing that makes my pants tighter but I do not want to get ahead of myself. I would imagine we are going to see direct competition within 18 months. If we can get to $15-$20 within 12 months and someone were to offer a 50% premium I think the BOD would be intrigued at $30/share (approx $750mm). Heck one of them just dumped his whole position in the $7.XX range (i voted against him in the last go around btw)???